9743

A METHOD FOR THE DIAGNOSIS AND TREATMENT OF COLORECTAL CANCER

Ben-Neriah Yinon, HUJI, School of Medicine - IMRIC, Immunology and Cancer Research

Category

LifeSciences and BioTechnology   

Keywords

colorectal cancer, gut microbiota, personalized medicine

Current development stage

             

For Pharmaceutical development: TRL4 - POC & Safety of candidate drug formulation is demonstrated in defined animal model

 

 

Application

Identifying, preventing, and treating patients at high risk for developing colorectal cancer.

Our Innovation

The present invention is based on the surprising finding that gut microbiota, and in particular polyphenol producing microbiota, promotes colorectal cancer, and has a clear pro-tumorigenic effect on patients with a specific genetic background.

Our innovation suggests a method to prevent and treat cancer by exposing the patient to gradually reduced amounts of the discovered specific polyphenol.

Technology

Personalized monitoring of microbiota and the associated metabolites content for colorectal cancer patients or people bearing high risk for the disease. The technology will also be used to prevent the development of  colorectal cancer in high risk patients as well as treat patients already afflicted by colorectal  cancer through dietary measures, antibiotic treatment, or administration of small molecules that reduce the amount of the specific polyphenol .

Contact for more information:

Mel Larrosa
VP Business Development Healthcare
+972-2-6586692
Contact ME: